Zimmer Biomet Holdings (ZBH) EBT (2009 - 2026)

Zimmer Biomet Holdings has reported EBT for 18 years, with the latest figure at $301.3 million in Q1 2026.

• For the quarter ending Q1 2026, EBT rose 31.57% year-over-year to $301.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 billion (up 29.03% YoY), and the FY2025 full-year result was $958.3 million, up 22.11% from the prior year.
• EBT for Q1 2026 stood at $301.3 million, up from $225.5 million in the prior quarter.
• The five-year high for EBT was $302.2 million in Q2 2024, with the low at $37.2 million in Q4 2024.
• Average EBT over 5 years is $221.0 million, with a median of $225.5 million recorded in 2025.
• Year-over-year, EBT sank 86.92% in 2024 and surged 506.18% in 2025.
• Tracing ZBH's EBT over 5 years: stood at $167.6 million in 2022, then soared by 69.75% to $284.5 million in 2023, then slumped by 86.92% to $37.2 million in 2024, then surged by 506.18% to $225.5 million in 2025, then soared by 33.61% to $301.3 million in 2026.
• The last three EBT figures came in at $301.3 million (Q1 2026), $225.5 million (Q4 2025), and $279.2 million (Q3 2025), per Business Quant data.

Peer Comparison